The Times of IndiaHealth
Cancer drug margins rise from 30% to 700%
Cancer drug margins are reported to have climbed from 30 percent in 2019 to 700 percent now. The brief claim gives no drug name, company, or explanation for the sharp increase, leaving important context unclear.
This card is an AI-assisted summary of reporting published by The Times of India. Read the original report before relying on it for medical, legal, financial, safety, or emergency decisions.